STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSStandard Exclusive License Agreement • September 29th, 2016 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Agreement is made effective May 1, 2016, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “ Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Alzamend Neuro Inc. (hereinafter called “Licensee”), a small corporation organized and existing under the laws of Delaware;
MANAGEMENT SERVICES AGREEMENT - AMENDEDManagement Services Agreement • September 29th, 2016 • Alzamend Neuro, Inc. • Pharmaceutical preparations • California
This AGREEMENT is made on May 1, 2016, at Santa Ana, Orange County, California between Avalanche International Corp. (hereinafter referred to as “Avalanche”), a Delaware corporation, located at 5940 S. Rainbow Blvd., Las Vegas, CA 89118 and Alzamend Neuro, Inc. (hereinafter referred to as “Alzamend”), a Delaware corporation, located at 50 W. Broadway, Salt Lake City, UT 84101. Avalanche and Alzamend are each referred to herein as a “Party” and collectively as the “Parties.”
SUBSCRIPTION AGREEMENT – NOTICE TO INVESTORSSubscription Agreement • September 29th, 2016 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.
ESCROW AGREEMENTEscrow Agreement • September 29th, 2016 • Alzamend Neuro, Inc. • Pharmaceutical preparations • Oregon
THIS ESCROW AGREEMENT is made as of the August18, 2016 by and between Alzamend Neuro, Inc.,. a corporation formed pursuant to the laws of the State of Delaware and having an office for business located at 50 W. Broadway, Third Floor, Salt Lake City, UT 84101 (the “Company”) and Transfer Online, Inc., a corporation formed pursuant to the laws of the State of Oregon having an office for business located at 512 SE Salmon, Portland, Oregon, 97214 (“Escrow Agent”).
